SOFIA (Bulgaria), July 18 (SeeNews) – Bulgarian drug distributor Sopharma Trading [BUL:SO5] said on Tuesday it has received approval from Serbia’s competition authority to acquire drug wholesaler Lekovit.
Lekovit’s current owner – Dragan Petkovic - will keep a minority stake in the company and will continue to act as the company's CEO, Sopharma Trading said in a bourse filing.
You can subscribe to our M&A newsletter here
In March Sopharma Trading said it would seek its shareholders' approval to take out two loans worth a total of 40 million levs ($23.6 million/20.45 million euro) to finance acquisitions in Bulgaria and Serbia.
Sopharma Trading is a unit of Bulgarian drug maker Sopharma [BUL:3JR].
Lekovit is active in the supply of pharmacies and other healthcare institutions with pharmaceutical products. The company has around a hundred employees and works with some 900 pharmacies across Serbia, data from its website shows.
As at 13:55 CET on Tuesday, Sopharma Trading shares traded 0.12% lower at 8.25 levs.
(1 euro = 1.95583 levs)